MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 29 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $574,676 | +24.0% | 445,485 | +26.9% | 0.02% | +17.6% |
| Q2 2023 | $463,300 | +7.9% | 350,985 | -42.2% | 0.02% | 0.0% |
| Q1 2023 | $429,442 | +84.4% | 607,500 | +95.7% | 0.02% | +54.5% |
| Q4 2022 | $232,875 | -12.8% | 310,500 | 0.0% | 0.01% | -15.4% |
| Q3 2022 | $267,000 | +13.6% | 310,500 | +47.9% | 0.01% | +18.2% |
| Q2 2022 | $235,000 | -3.3% | 210,000 | -3.2% | 0.01% | 0.0% |
| Q1 2022 | $243,000 | +125.0% | 217,051 | +221.6% | 0.01% | +83.3% |
| Q4 2021 | $108,000 | -81.5% | 67,501 | -72.0% | 0.01% | -79.3% |
| Q3 2021 | $584,000 | -70.6% | 241,413 | -61.5% | 0.03% | -62.3% |
| Q2 2021 | $1,986,000 | +836.8% | 626,421 | +898.0% | 0.08% | +1000.0% |
| Q1 2021 | $212,000 | -87.1% | 62,767 | -86.4% | 0.01% | -91.7% |
| Q4 2020 | $1,647,000 | +41.7% | 460,051 | +3.7% | 0.08% | +6.3% |
| Q3 2020 | $1,162,000 | – | 443,517 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |